Package Insert: Information for the Patient
Forxiga 5 mg Film-Coated Tablets
Forxiga 10 mg Film-Coated Tablets
dapagliflozina
Read this package insert carefully before starting to take this medicine, as it contains important information for you.
What is Forxiga
Forxiga contains the active ingredient dapagliflozina. It belongs to a group of medicines called "inhibitors of the sodium-glucose cotransporter 2 (SGLT2)". They work by blocking the SGLT2 protein in the kidneys. By blocking this protein, sugar in the blood (glucose), salt (sodium), and water are eliminated from the body through urine.
What is Forxiga used for
Forxiga is used to treat:
What is type 2 diabetes and how does Forxiga help?
What is heart failure and how does Forxiga help?
What is chronic kidney disease and how does Forxiga help?
Do not take Forxiga
Warnings and precautions
Contact a doctor or the nearest hospital immediately
Diabetic ketoacidosis:
If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital immediately and do not take this medication.
Fournier's gangrene:
Contact a doctor, pharmacist or nurse before starting to take Forxiga
If any of the above situations apply to you (or you are unsure), speak with your doctor, pharmacist or nurse before taking Forxiga.
Diabetes and foot care
If you have diabetes, it is essential to regularly inspect your feet and follow any other foot care advice provided by your healthcare professional.
Blood glucose in urine
Due to how Forxiga works, your urine will test positive for glucose while taking this medication.
Children and adolescents
Forxiga can be used in children aged 10 years or older for the treatment of type 2 diabetes. There are no available data in children under 10 years of age.
Forxiga is not recommended in children or adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, as it has not been studied in these patients.
Taking Forxiga with other medications
Inform your doctor, pharmacist or nurse if you are taking, have taken recently or may need to take any other medication.
Especially inform your doctor:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before taking this medication. You should stop taking this medication if you become pregnant, as it is not recommended for use during the second and third trimesters of pregnancy. Consult your doctor about the best way to control blood glucose during pregnancy.
Consult your doctor if you want to breastfeed before taking this medication. Do not use Forxiga during breastfeeding. It is unknown whether this medication passes into human breast milk.
Driving and operating machinery
Forxiga has a negligible or insignificant effect on the ability to drive or operate machinery.
Taking this medication with other medications called sulfonilureas or with insulin may cause very low blood sugar (hypoglycemia), which may cause symptoms such as trembling, sweating and visual disturbances that may affect your ability to drive or operate machinery.
Do not drive or use tools or machinery if you feel dizzy while taking Forxiga.
Forxiga contains lactose
Forxiga contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor, pharmacist, or nurse again.
What dose should you take
How to take this medication
Your doctor may prescribe Forxiga along with other medication(s). Remember to take these other medication(s) following your doctor's instructions. This will help you achieve the best results for your health.
A healthy diet and exercise can help your body use blood sugar better. If you have diabetes, it is essential that you follow any diet and exercise program recommended by your doctor while taking Forxiga.
If you take more Forxiga than you should
If you take more Forxiga tablets than you should, consult your doctor or go to the hospital immediately. Bring the medication packaging with you.
If you forget to take Forxiga
What to do if you forget to take a tablet depends on how much time is left until your next dose.
If you interrupt treatment with Forxiga
Do not stop taking Forxiga without consulting your doctor first. If you have diabetes, your blood sugar may increase without this medication.
If you have any other questions about using this product, ask your doctor, pharmacist, or nurse.
Like all medicines, Forxiga may cause side effects, although not everyone will experience them.
Contact a doctor or the nearest hospital immediately if you experience any of the following side effects:
These are the signs of angioedema:
These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions):
This may occur regardless of your blood sugar levels. Your doctor will decide whether to temporarily or permanently stop your treatment with Forxiga.
Stop taking Forxiga and consult a doctor immediately if you notice any of these severe side effects:
These are the signs of a severe urinary tract infection:
Although it is not very common, if you notice blood in your urine, inform your doctor immediately.
Contact your doctor as soon as possible if you experience any of the following side effects:
These are the signs of low blood sugar levels:
Your doctor will explain how to treat low blood sugar levels and what to do if you experience any of the above symptoms.
Other side effects of treatment with Forxiga:
Frequent
Rare (may affect up to 1 in 100 people)
Very rare
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through thenational notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack or container after EXP/CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.
Composition of Forxiga
Each film-coated tablet of Forxiga 5 mg contains dapagliflozina propanodiol monohydrate equivalent to 5 mg of dapagliflozina.
Each film-coated tablet of Forxiga 10 mg contains dapagliflozina propanodiol monohydrate equivalent to 10 mg of dapagliflozina.
Appearance of the product and contents of the pack
The film-coated tablets of Forxiga 5 mg are yellow and round with a diameter of 0.7 cm. They have “5” engraved on one side and “1427” on the other.
The film-coated tablets of Forxiga 10 mg are yellow and rhomboid with a diagonal of approximately 1.1 x 0.8 cm. They have “10” engraved on one side and “1428” on the other.
Forxiga 5 mg tablets are available in aluminium blisters in pack sizes of 14, 28 or 98 film-coated tablets in non-precortated calendar blisters and in pack sizes of 30x1 or 90x1 film-coated tablets in precortated single-dose blisters.
Forxiga 10 mg tablets are available in aluminium blisters in pack sizes of 14, 28 or 98 film-coated tablets in non-precortated calendar blisters and in pack sizes of 10x1, 30x1 or 90x1 film-coated tablets in precortated single-dose blisters.
Only some pack sizes may be marketed in your country.
Marketing authorisation holder
AstraZeneca AB
SE-151 85 Södertälje
Sweden
Responsible for manufacturing
AstraZeneca AB
Gärtunavägen
SE-152 57 Södertälje
Sweden
AstraZeneca UK Limited
Silk Road Business Park
Macclesfield
SK10 2NA
United Kingdom
For more information about this medicine, please contact the local representative of the marketing authorisation holder:
België/Belgique/Belgien AstraZeneca S.A./N.V. Tel: +32 2 370 48 11 | Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660550 |
Luxembourg/Luxemburg AstraZeneca S.A./N.V. Tél/Tel: +32 2 370 48 11 | |
Ceská republika AstraZeneca Czech Republic s.r.o. Tel: +420 222 807 111 | Magyarország AstraZeneca Kft. Tel.: +36 1 883 6500 |
Danmark AstraZeneca A/S Tlf: +45 43 66 64 62 | Malta Associated Drug Co. Ltd Tel: +356 2277 8000 |
Deutschland AstraZeneca GmbH Tel: +49 40 809034100 | Nederland AstraZeneca BV Tel: +3185808 9900 |
Eesti AstraZeneca Tel: +372 6549 600 | Norge AstraZeneca AS Tlf: +47 21 00 64 00 |
Ελλáδα AstraZeneca A.E. Τηλ: +30 2 106871500 | Österreich AstraZeneca Österreich GmbH Tel: +43 1 711 31 0 |
España AstraZeneca Farmacéutica Spain, S.A. Tel: +34 91 301 91 00 | Polska AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 00 |
France AstraZeneca Tél: +33 1 41 29 40 00 | Portugal AstraZeneca Produtos Farmacêuticos, Lda. Tel: +351 21 434 61 00 |
Hrvatska AstraZeneca d.o.o. Tel: +385 1 4628 000 | România AstraZeneca Pharma SRL Tel: +40 21 317 60 41 |
Ireland AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7100 | Slovenija AstraZeneca UK Limited Tel: +386 1 51 35 600 |
Ísland Vistor hf. Sími:+354 535 7000 | Slovenská republika AstraZeneca AB, o.z. Tel: +421 2 5737 7777 |
Italia AstraZeneca S.p.A. Tel: +39 02 00704500 | Suomi/Finland AstraZeneca Oy Puh/Tel: +358 10 23 010 |
Κúπρος Αλeκτωρ ΦaρµaκeυτικnΛτδ Τηλ: +357 22490305 | Sverige AstraZeneca AB Tel: +46 8 553 26 000 |
Latvija SIA AstraZeneca Latvija Tel: +371 67377100 | United Kingdom (Northern Ireland) AstraZeneca UK Ltd Tel: +44 1582 836 836 |
Last update of this leaflet:
Other sources of information
Further information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.